Lung cancer is the most common cause of cancer-related mortality worldwide and a
therapeutic challenge. Recent success with antibodies blocking immune checkpoints in non …

Abstract Treatment of lung cancer remains a challenge, and lung cancer is still the leading
cause of cancer‐related mortality. Immunotherapy has previously failed in lung cancer but …

Simple Summary The lung cancer treatment paradigm has been completely changed by
immunotherapy; however, less than half of the treated patients obtain a response, and an …

Lung cancer is the leading cause of cancer-related mortality worldwide, and more than 80%
of cases are of non-small cell lung cancer. Although chemotherapy and molecularly targeted …

Background Lung cancer is the most common cause of cancer-related death in the United
States, yet traditional chemotherapy fails to provide long-term benefit for many patients. New …

Introduction. Immunotherapy has become an increasingly important therapeutic strategy for
those with cancer, with phase III studies demonstrating survival advantages in melanoma …

Non-small cell lung cancer (NSCLC) remains the leading cause of cancer related mortality
worldwide and despite some advances in therapy the overall prognosis remains …

Lung cancer is the leading cause of cancer mortality and non-small cell lung cancer
(NSCLC) accounts for more than 85% of all lung cancers. Platinum-based doublet …

Lung cancer is the leading cause of cancer-related mortality in the United States. 1 Non–
small cell lung cancer (NSCLC) comprises approximately 85% of all lung cancer cases. 2 …

Recent breakthroughs in translating the early development of immunomodulatory antibodies
into the clinic, notably with the anti–cytotoxic T-lymphocyte antigen-4 antibody, ipilimumab …